CFS Investment Advisory Services, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1845688 TOTOWA, NJ

Position in BMY

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$542,492

-$33,864 QoQ

Shares Held

9,415

-0.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#1,486

of 2,506 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CFS Investment Advisory Services, LLC holds $28,816,926 across 9 Drug Manufacturers - General names. BMY ranks #7 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	29,062	$7,380,876
2	ABBV	AbbVie Inc.	24,175	$6,083,397
3	LLY	ELI LILLY & Co	4,838	$5,802,842
4	MRK	Merck & Co., Inc.	26,467	$3,401,009
5	AMGN	Amgen Inc	9,251	$3,349,972
6	GILD	Gilead Sciences, Inc.	11,660	$1,473,124
7	BMY	Bristol Myers Squibb Co This page	9,415	$542,492
8	PFE	Pfizer Inc	16,411	$395,176

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$542,492	9,415	-0.9%	Shares	Sole	2026-07-16
2026-03-31	$576,356	9,503	+1.8%	Shares	Sole	2026-04-29
2025-12-31	$503,314	9,331	-18.1%	Shares	Sole	2026-02-10
2025-09-30	$514,004	11,397	-6.6%	Shares	Sole	2025-10-31
2025-06-30	$564,691	12,199	-52.3%	Shares	Sole	2025-08-11
2025-03-31	$1,558,233	25,549	+3.5%	Shares	Sole	2025-05-12
2024-12-31	$1,396,522	24,691	-12.4%	Shares	Sole	2025-01-21
2024-09-30	$1,457,515	28,170	+14.9%	Shares	Sole	2024-11-12
2024-06-30	$1,017,816	24,508	+71.6%	Shares	Sole	2024-08-13
2023-06-30	$913,206	14,280	+87.8%	Shares	Sole	2023-07-21
2022-06-30	$585,431	7,603	-98.6%	Shares	Sole	2022-08-16
2022-03-31	$8,000	553,202	+7146.6%	Shares	Sole	2022-05-27
2021-12-31	$475,979	7,634	+117.3%	Shares	Sole	2022-02-14
2021-09-30	$207,864	3,513	—	Shares	Sole	2021-11-19
No filing history on record for this holder in this stock.